These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35178780)

  • 1. Brain pathology and cognitive scores prior to onset of late-life depression.
    Almdahl IS; Agartz I; Hugdahl K; Korsnes MS;
    Int J Geriatr Psychiatry; 2022 Mar; 37(3):. PubMed ID: 35178780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden.
    Chan CK; Pettigrew C; Soldan A; Zhu Y; Wang MC; Albert M; Rosenberg PB;
    J Alzheimers Dis; 2022; 86(3):1415-1426. PubMed ID: 35213370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Determines Cognitive Functioning in the Oldest-Old? The EMIF-AD 90+ Study.
    Legdeur N; Badissi M; Yaqub M; Beker N; Sudre CH; Ten Kate M; Gordon MF; Novak G; Barkhof F; van Berckel BNM; Holstege H; Muller M; Scheltens P; Maier AB; Visser PJ
    J Gerontol B Psychol Sci Soc Sci; 2021 Sep; 76(8):1499-1511. PubMed ID: 32898275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.
    Racine AM; Koscik RL; Berman SE; Nicholas CR; Clark LR; Okonkwo OC; Rowley HA; Asthana S; Bendlin BB; Blennow K; Zetterberg H; Gleason CE; Carlsson CM; Johnson SC
    Brain; 2016 Aug; 139(Pt 8):2261-74. PubMed ID: 27324877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer's Disease Neuroimaging Initiative Depression Project.
    Mackin RS; Insel PS; Landau S; Bickford D; Morin R; Rhodes E; Tosun D; Rosen HJ; Butters M; Aisen P; Raman R; Saykin A; Toga A; Jack C; Koeppe R; Weiner MW; Nelson C;
    Biol Psychiatry; 2021 Apr; 89(8):757-765. PubMed ID: 32980132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory.
    Han JW; Maillard P; Harvey D; Fletcher E; Martinez O; Johnson DK; Olichney JM; Farias ST; Villeneuve S; Jagust W; Mungas D; DeCarli C
    Neurology; 2020 Nov; 95(19):e2622-e2634. PubMed ID: 32732300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration.
    Busatto Filho G; Duran FLS; Squarzoni P; Coutinho AMN; Rosa PGP; Torralbo L; Pachi CGDF; da Costa NA; Porto FHG; Carvalho CL; Brucki SMD; Nitrini R; Forlenza OV; Leite CDC; Buchpiguel CA; de Paula Faria D
    J Neurosci Res; 2021 Feb; 99(2):481-501. PubMed ID: 33073383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal changes in hippocampal texture from healthy aging to Alzheimer's disease.
    Wearn A; Raket LL; Collins DL; Spreng RN;
    Brain Commun; 2023; 5(4):fcad195. PubMed ID: 37465755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
    Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression.
    Diniz BS; Teixeira AL; Machado-Vieira R; Talib LL; Radanovic M; Gattaz WF; Forlenza OV
    J Gerontol B Psychol Sci Soc Sci; 2014 Nov; 69(6):845-51. PubMed ID: 25149921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
    Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
    JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults.
    Biddle KD; Jacobs HIL; d'Oleire Uquillas F; Zide BS; Kirn DR; Properzi MR; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
    JAMA Netw Open; 2020 Feb; 3(2):e200121. PubMed ID: 32101313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression.
    Rhodes E; Insel PS; Butters MA; Morin R; Bickford D; Tosun D; Gessert D; Rosen HJ; Aisen P; Raman R; Landau S; Saykin A; Toga A; Jack CR; Weiner MW; Nelson C; Mackin S; ;
    J Alzheimers Dis; 2021; 80(3):991-1002. PubMed ID: 33682706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.